76
Views
2
CrossRef citations to date
0
Altmetric
Hypothesis

Metabolic abnormalities in pituitary adenoma patients: a novel therapeutic target and prognostic factor

, , &
Pages 357-361 | Published online: 05 Aug 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Qian Zhang, Peng Chen, Renli Tian, Jingteng He, Qipeng Han & Lianhui Fan. (2022) Metabolic Syndrome is an Independent Risk Factor for Fuhrman Grade and TNM Stage of Renal Clear Cell Carcinoma. International Journal of General Medicine 15, pages 143-150.
Read now

Articles from other publishers (1)

Kexia Fan, Xiao Ding, Zhenle Zang, Yin Zhang, Xiaoshuang Tang, Xiangdong Pei, Qingbo Chen, Huachun Yin, Xin Zheng, Yong Chen, Song Li & Hui Yang. (2022) Drp1-Mediated Mitochondrial Metabolic Dysfunction Inhibits the Tumor Growth of Pituitary Adenomas. Oxidative Medicine and Cellular Longevity 2022, pages 1-23.
Crossref